AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35576073 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 3 months or until stone free
Number of subjects: 0
Study 35576073 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 0
Study 35576073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33838898 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding (EEN)
Number of subjects: 156
Study 33838898 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional feeding)
Number of subjects: 156
Study 34999377 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined non-pharmacological interventions (periodic reorientation, cognitive stimulation, correction of sensory deficits, environmental management, sleep promotion)
Number of subjects: 144
Study 34999377 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 144
Study 34999377 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined non-pharmacological interventions
Number of subjects: 144
Study 32918768 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry immersion (DI) for 5 days
Number of subjects: 20
Study 32918768 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study 35848977 — intervention group
Group type: EXPERIMENTAL
Intervention: CHEP + TQABC
Number of subjects: 500
Study 35848977 — intervention group
Group type: COMPARATOR
Intervention: CHEP formula placebo + TQABC formula placebo
Number of subjects: 500
Study 33804348 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 45
Study 33804348 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 32870318 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic training
Number of subjects: 60
Study 32870318 — intervention group
Group type: COMPARATOR
Intervention: Sensory motor training
Number of subjects: 60
Study 32870318 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 32870318 — intervention group
Group type: COMPARATOR
Intervention: Isokinetic training, Sensory motor training, Control
Number of subjects: 60
Study 34715934 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day ergothioneine for 12 weeks
Number of subjects: 0
Study 34715934 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day ergothioneine for 12 weeks
Number of subjects: 0
Study 34715934 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 0
Study 32726103 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-oxide containing formulations
Number of subjects: 0
Study 32726103 — intervention group
Group type: COMPARATOR
Intervention: Mineral SPF 50+ sunscreen
Number of subjects: 0
Study 33200891 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 10584
Study 33200891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10584
Study 32086888 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhuyuan soup combined with fumigation and oral administration
Number of subjects: 60
Study 32086888 — intervention group
Group type: COMPARATOR
Intervention: Budesonide nasal spray (western medicine group)
Number of subjects: 60
Study 32138561 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 40
Study 32138561 — intervention group
Group type: EXPERIMENTAL
Intervention: HHHFNC
Number of subjects: 40
Study 33610417 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis (BIA) with a new predictive equation
Number of subjects: 315
Study 32888318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined 0.01% atropine with orthokeratology (AOK)
Number of subjects: 53
Study 32888318 — intervention group
Group type: COMPARATOR
Intervention: Orthokeratology (OK)
Number of subjects: 53
Study 34363518 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice-based training program
Number of subjects: 62
Study 34363518 — intervention group
Group type: COMPARATOR
Intervention: Theory-based training program
Number of subjects: 62
Study 33861194 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline (1 mg)
Number of subjects: 8014
Study 33861194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8014
Study 33551026 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of allergenic solids from age 3 months alongside breast-feeding
Number of subjects: 1303
Study 33551026 — intervention group
Group type: COMPARATOR
Intervention: Exclusively breast-fed infants (control group)
Number of subjects: 1303
Study 36063792 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed care bundle of intensive blood pressure lowering, glycemic control, antipyrexia, and anticoagulation reversal treatment
Number of subjects: 8360
Study 36063792 — intervention group
Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 8360
Study 33414540 — intervention group
Group type: EXPERIMENTAL
Intervention: Mature desmoplastic reaction (N = 638)
Number of subjects: 991
Study 33414540 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate desmoplastic reaction (N = 294)
Number of subjects: 991
Study 33414540 — intervention group
Group type: EXPERIMENTAL
Intervention: Immature desmoplastic reaction (N = 59)
Number of subjects: 991
Study 33414540 — intervention group
Group type: EXPERIMENTAL
Intervention: DR classification
Number of subjects: 991
Study 33414540 — intervention group
Group type: EXPERIMENTAL
Intervention: DR categorisation
Number of subjects: 991
Study 32579229 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based interprofessional education
Number of subjects: 29
Study 32579229 — intervention group
Group type: COMPARATOR
Intervention: Online interprofessional education
Number of subjects: 29
Study 35877385 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on age, PI-RADS v2.1, and CEUS
Number of subjects: 490
Study 35877385 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 490
Study 32981468 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent complex training (CPX)
Number of subjects: 38
Study 32981468 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy strength training (HST)
Number of subjects: 38
Study 32981468 — intervention group
Group type: COMPARATOR
Intervention: Endurance-strength training (EST)
Number of subjects: 38
Study 35658775 — intervention group
Group type: EXPERIMENTAL
Intervention: Opt-out group (assigned an individual appointment)
Number of subjects: 2000
Study 35658775 — intervention group
Group type: COMPARATOR
Intervention: Opt-in group (invited to set an appointment)
Number of subjects: 2000
Study 34856568 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum PTSD symptoms assessed by TES (Traumatic Event Scale)
Number of subjects: 3891
Study 34856568 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum PTSD provisional diagnosis assessed by IES‐R (Impact of Event Scale‐Revised)
Number of subjects: 3891
Study 34856568 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum PTSD provisional diagnosis assessed by TES
Number of subjects: 3891
Study 34856568 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors associated with PTSD symptoms
Number of subjects: 3891
Study 32270496 — intervention group
Group type: COMPARATOR
Intervention: 500 mL crystalloid fluid bolus over 30 minutes
Number of subjects: 130
Study 32270496 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour follow-up without interventions
Number of subjects: 130
Study 35279277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia (n=14)
Number of subjects: 27
Study 35279277 — intervention group
Group type: COMPARATOR
Intervention: Propofol anaesthesia (n=13)
Number of subjects: 27
Study 35279277 — intervention group
Group type: EXPERIMENTAL
Intervention: Both anaesthesia types
Number of subjects: 27
Study 616593029 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (ICBT) program
Number of subjects: 91
Study 36306989 — intervention group
Group type: EXPERIMENTAL
Intervention: Single developing lines
Number of subjects: 240
Study 36306989 — intervention group
Group type: EXPERIMENTAL
Intervention: Double developing lines
Number of subjects: 240
Study 36306989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no developing lines)
Number of subjects: 240
Study 34519717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise that expended 20 kcal per kilogram of weight per week (20 KKW)
Number of subjects: 42
Study 34519717 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise that expended 8 kcal/kg of body weight per week (8 KKW)
Number of subjects: 42
Study 34519717 — intervention group
Group type: COMPARATOR
Intervention: Healthy living control group
Number of subjects: 42
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines or z-hypnotics dispensed
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentinoids dispensed
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean daily dose of benzodiazepines or z-hypnotics
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean daily dose of pregabalin
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of gabapentinoids with benzodiazepines or z-hypnotics
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of non-OAT opioids with benzodiazepines or z-hypnotics
Number of subjects: 10371
Study 32334602 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing OAT
Number of subjects: 10371
Study 34330073 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRS-based mHealth intervention
Number of subjects: 286
Study 32560926 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-11 guidelines
Number of subjects: 1717
Study 32560926 — intervention group
Group type: COMPARATOR
Intervention: ICD-10 guidelines
Number of subjects: 1717
Study 34757704 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold spinal mud pack (CSMP)
Number of subjects: 100
Study 34757704 — intervention group
Group type: COMPARATOR
Intervention: Prone rest
Number of subjects: 100
Study 34490179 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 2166
Study 34490179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (CRF)
Number of subjects: 2166
Study 34490179 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior
Number of subjects: 2166
Study 35998897 — intervention group
Group type: EXPERIMENTAL
Intervention: Calanus oil (2 g/day)
Number of subjects: 71
Study 35998897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 34700446 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose treatment arm (74 Gy)
Number of subjects: 488
Study 34700446 — intervention group
Group type: COMPARATOR
Intervention: Low-dose treatment arm (60 Gy)
Number of subjects: 488
Study 34700446 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose to cardiac sub-regions
Number of subjects: 488
Study 34700446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean lung dose
Number of subjects: 488
Study 34700446 — intervention group
Group type: EXPERIMENTAL
Intervention: Log tumor volume
Number of subjects: 488
Study 34700446 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart v5 and v30
Number of subjects: 488
Study 35897470 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxic Training (IHE) group (n = 12)
Number of subjects: 24
Study 35897470 — intervention group
Group type: COMPARATOR
Intervention: Intermittent Normoxia group (NA) (n = 12)
Number of subjects: 24
Study 32723928 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi programs
Number of subjects: 66
Study 32723928 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 66
Study 32723928 — intervention group
Group type: EXPERIMENTAL
Intervention: Dancing
Number of subjects: 66
Study 32723928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball games
Number of subjects: 66
Study 34223605 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy for 52 weeks
Number of subjects: 69
Study 34223605 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 52 weeks
Number of subjects: 69
Study 34775648 — intervention group
Group type: EXPERIMENTAL
Intervention: Red dichromatic imaging (RDI)
Number of subjects: 404
Study 34775648 — intervention group
Group type: COMPARATOR
Intervention: White light imaging (WLI)
Number of subjects: 404
Study 33338315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 60
Study 33338315 — intervention group
Group type: EXPERIMENTAL
Intervention: Metacognitive Therapy (MCT)
Number of subjects: 60
Study 35510720 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chest physiotherapy
Number of subjects: 50
Study 35510720 — intervention group
Group type: COMPARATOR
Intervention: General care (Control)
Number of subjects: 50
Study 32638173 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) administered 48 hours prior to surgery
Number of subjects: 200
Study 32638173 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) started on the day of surgery
Number of subjects: 200
Study 32638173 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic enzyme therapy (SET) started immediately after surgery
Number of subjects: 200
Study 32638173 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs (diclofenac) started 3 hours after surgery (Control group)
Number of subjects: 200
Study 32638173 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C, D)
Number of subjects: 200
Study 36447152 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with paclitaxel/cisplatin/5‐fluorouracil (TPF) followed by concurrent chemoradiotherapy (CCRT)
Number of subjects: 142
Study 36447152 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (CCRT) alone
Number of subjects: 142
Study 34193637 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60
Study 34193637 — intervention group
Group type: COMPARATOR
Intervention: Sham ESWT (Control)
Number of subjects: 60
Study 36209355 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical vestibular nerve stimulation for 12 weeks
Number of subjects: 30
Study 36209355 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 30
Study 34765451 — intervention group
Group type: COMPARATOR
Intervention: tamsulosin
Number of subjects: 140
Study 34765451 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin plus tadalafil
Number of subjects: 140
Study 32702334 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for 6 months
Number of subjects: 1280
Study 32702334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1280
Study 35193168 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo effects with clotting factors; effect appears modest at best.
Number of subjects: 0
Study 35193168 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cell transfusions; hints that placebo effects might operate.
Number of subjects: 0
Study 35193168 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocebo effects with transfusions; very little published information available.
Number of subjects: 0
Study 32843265 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application education (n = 30)
Number of subjects: 60
Study 32843265 — intervention group
Group type: COMPARATOR
Intervention: Conventional clinical education (n = 30)
Number of subjects: 60
Study 36422232 — intervention group
Group type: EXPERIMENTAL
Intervention: DNN model 1 using CRP and ESR
Number of subjects: 74
Study 36422232 — intervention group
Group type: EXPERIMENTAL
Intervention: DNN model 2 using ESR and SUVmax
Number of subjects: 74
Study 36422232 — intervention group
Group type: EXPERIMENTAL
Intervention: DNN model 3 using CRP and SUVmax
Number of subjects: 74
Study 36422232 — intervention group
Group type: EXPERIMENTAL
Intervention: DNN model 4 using ESR, CRP, and SUVmax
Number of subjects: 74
Study 34514635 — intervention group
Group type: EXPERIMENTAL
Intervention: First line treatment according to national guidelines
Number of subjects: 10000
Study 34514635 — intervention group
Group type: EXPERIMENTAL
Intervention: National registries data
Number of subjects: 10000
Study 34514635 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroups of patients with comorbidity and high-risk MM
Number of subjects: 10000
Study 34514635 — intervention group
Group type: EXPERIMENTAL
Intervention: New and better treatments introduced
Number of subjects: 10000
Study 33001536 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop Diabeloop for highly unstable diabetes (DBLHU)
Number of subjects: 7
Study 33001536 — intervention group
Group type: COMPARATOR
Intervention: Open-loop predictive low glucose suspend (PLGS)
Number of subjects: 7
Study 35136596 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care CD4 testing
Number of subjects: 603
Study 35136596 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care central laboratory CD4 testing
Number of subjects: 603
Study 35136596 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care CD4 testing (advanced HIV disease, CD4 < 200 cells/mm3)
Number of subjects: 603
Study 35136596 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care central laboratory CD4 testing (advanced HIV disease, CD4 < 200 cells/mm3)
Number of subjects: 603
Study 32100108 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetabular Defect Classification (ADC) grading
Number of subjects: 287
Study 32100108 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetabular Defect Classification (ADC) grading by 5 observers
Number of subjects: 287
Study 34712863 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg daily for 42 days)
Number of subjects: 72
Study 34712863 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for 42 days)
Number of subjects: 72
Study 32559401 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood product transfusion
Number of subjects: 0
Study 32559401 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid infusion
Number of subjects: 0
Study 32559401 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma and albumin
Number of subjects: 0
Study 35543302 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolite system (IS)
Number of subjects: 48
Study 35543302 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation (RDI)
Number of subjects: 48
Study 35543302 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton roll isolation (CRI)
Number of subjects: 48
Study 33624688 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl 2ºC
Number of subjects: 45
Study 33624688 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl 45ºC
Number of subjects: 45
Study 33624688 — intervention group
Group type: COMPARATOR
Intervention: NaOCl 2ºC, NaOCl 25ºC, NaOCl 45ºC
Number of subjects: 45
Study 32100960 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP)
Number of subjects: 1935
Study 32100960 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP concentrations ≥ 28.0 μg/ml at week 12
Number of subjects: 1935
Study 32100960 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP concentrations ≥ 17.6 μg/ml at week 24
Number of subjects: 1935
Study 35237867 — intervention group
Group type: EXPERIMENTAL
Intervention: EIMD in Hot
Number of subjects: 10
Study 35237867 — intervention group
Group type: COMPARATOR
Intervention: EIMD in Temp
Number of subjects: 10
Study 34606322 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal screening for ovarian cancer
Number of subjects: 0
Study 34606322 — intervention group
Group type: EXPERIMENTAL
Intervention: US screening for ovarian cancer
Number of subjects: 0
Study 34606322 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32167550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided glossopharyngeal nerve block (UGPNB) with 1.5 mL of 0.5% ropivacaine and 20 mg of methylprednisolone
Number of subjects: 51
Study 32167550 — intervention group
Group type: COMPARATOR
Intervention: Landmark glossopharyngeal nerve block (GPNB)
Number of subjects: 51
Study 32167550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided glossopharyngeal nerve block (UGPNB)
Number of subjects: 51
Study 36091794 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g LSZ capsules three times a day for 90 days
Number of subjects: 1376
Study 36091794 — intervention group
Group type: COMPARATOR
Intervention: Placebo LSZ capsules for 90 days
Number of subjects: 1376
Study 33405368 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid‐based peanut paste
Number of subjects: 80
Study 33405368 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanilla biscuit
Number of subjects: 80
Study 34038300 — intervention group
Group type: EXPERIMENTAL
Intervention: WFG LASIK
Number of subjects: 87
Study 34038300 — intervention group
Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 87
Study 32967406 — intervention group
Group type: EXPERIMENTAL
Intervention: High-voltage IAPRF
Number of subjects: 57
Study 32967406 — intervention group
Group type: COMPARATOR
Intervention: Low-voltage IAPRF
Number of subjects: 57
Study 35180283 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based care program (12 weeks)
Number of subjects: 116
Study 35180283 — intervention group
Group type: COMPARATOR
Intervention: Standard care (medication advice, rehabilitation exercise, nurse follow-up)
Number of subjects: 116
Study 34102075 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic stabilization
Number of subjects: 64
Study 34102075 — intervention group
Group type: COMPARATOR
Intervention: Open stabilization
Number of subjects: 64
Study 34102075 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-track shoulders (8 out of 56 with MRI studies)
Number of subjects: 64
Study 34102075 — intervention group
Group type: EXPERIMENTAL
Intervention: On-track shoulders (48 out of 56 with MRI studies)
Number of subjects: 64
Study 33561862 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge vitrectomy
Number of subjects: 80
Study 33561862 — intervention group
Group type: COMPARATOR
Intervention: 23-gauge vitrectomy
Number of subjects: 80